ICaps by Alcon ICaps Lutein Enriched Eye Multivitamin - 100 Tablets

ICaps MV Lutein Enriched Multivitamin provides high levels of lutein and zeaxanthin specifically for eye health in a multivitamin formula for overall body health in one formulation. ICaps Lutein Enriched Eye Multivitamin combines eye, body vitamin and mineral needed in one formulation for increased convenience. ICaps by Alcon tablets are coated for delayed-release for less stomach upset and better absorption. Additional benefits of ICaps:

• Free of Vitamin A for those who should avoid beta-carotene.
• Specific lifestyles considerations such as smoking should be considered when choosing the proper formulation.
• This multivitamin contains the most potent ingredients found in the AREDS formula tested by National Eye Institute.
• Confidence in a trusted formulation.
• Developed by Alcon, the global leader in eye care products.

About ICaps by Alcon:
For more than 65 years, Alcon has focused on helping people worldwide see better through their core competencies – research and development, manufacturing and sales. They know their customers – health care professionals, patients and their families – rely on us to produce the very best. As such, they seek the most promising outside partnerships as well as passionate associates to join the Alcon team, all in an effort to support their mission.

To provide innovative products that enhance quality of life by helping people see better. They accomplish this by partnering with eye care professionals around the world to advance the treatment of eye disease and help people experience the best vision possible. They are committed to conducting all of their business activities to the highest ethical and legal standards and are committed to quality and continuous improvement in everything they do – from exceeding regulatory standards for sterilization in manufacturing environments to surpassing government expectations for safety and efficacy of their products. There isn't an Alcon associate anywhere in the world who isn't willing to go one more step to make each product that much better.

Alcon is currently developing products to treat many pressing eye health needs, such as cataracts, glaucoma, age-related macular degeneration, refractive errors, ocular allergies, dry eye, infection and inflammation. Alcon is planning to spend approximately USD 4 billion over the next five years to drive research and new product development in eye care. As part of Novartis, Alcon also will be able to leverage the capabilities and resources of the Novartis Institutes for BioMedical Research (NIBR), to accelerate innovation for the eye.

Alcon employs approximately 5,800 individuals to manufacture their products at many plants around the world. They organize their manufacturing facilities along eye care product categories, with most plants primarily dedicated to manufacturing either surgical equipment and devices, pharmaceutical as well as contact lens and lens care products. Their functional division of plants reflects the unique technical skills required of associates in these two manufacturing environments as well as the differences in regulatory requirements governing the production of surgical devices and pharmaceuticals.

They operate a continuous improvement program that involves activities such as quality improvements and cycle-time reductions. Alcon also makes sure to maintain Good Manufacturing Practices through year-round training of their direct labor manufacturing staff. Their professional associates are trained in various aspects of management, regulatory and technical issues through a combination of in-house seminars, local university classes and trade meetings.